Tasly Pharmaceutical Group Co Ltd - Company Profile
Powered by
All the data and insights you need on Tasly Pharmaceutical Group Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Tasly Pharmaceutical Group Co Ltd Strategy Report
- Understand Tasly Pharmaceutical Group Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Tasly Pharmaceutical Group Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
11 Jul 2022 | Tasly Pharma Enters into Joint Venture with Mauna Kea Technologies | Partnership | - |
Tasly Pharmaceutical Group Co Ltd
Mauna Kea Technologies SAS
|
27 Dec 2021 | Tasly Biopharma Enters into Licensing Agreement with Sutro Biopharma | Licensing Agreement |
Tasly Biopharmaceuticals Co Ltd
|
Sutro Biopharma Inc
|
16 Nov 2020 | Tasly Invests USD75.67 Million in Yunnan Maye Biological Technology (Shang Tianhuo Yunma) | Equity Offering |
Tasly Pharmaceutical Group Co Ltd
|
Yunnan Maye Biological Technology Co., Ltd
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer